FDA Approves Dysport for Use Against Wrinkles

There is a new wrinkle fighter in town. The FDA has approved Medicis’ botulium toxin drug, Dysport. They plan to release the drug for public use within the next two months. This marks the first time that Botox giant Allergan will have competition in the wrinkle, anti-aging market in the U.S. More news to follow.